Immunologic defects in melanoma patients: lack of effect of BCG therapy. 1977

M J Gersten, and E M Hadden, and M H Kaplan, and C M Pinsky, and D Armstrong, and J W Hadden

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D004137 Dinitrochlorobenzene A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds. 1-Chloro-2,4-Dinitrobenzene,2,4-Dinitrochlorobenzene,Benzene, 1-Chloro-2,4-Dinitro-,Chlorodinitrobenzene,DNCB,1 Chloro 2,4 Dinitrobenzene,2,4 Dinitrochlorobenzene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001500 BCG Vaccine An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity. Bacillus Calmette Guerin Vaccine,Calmette Guerin Bacillus Vaccine,Calmette's Vaccine,Calmette Vaccine,Calmettes Vaccine,Vaccine, BCG,Vaccine, Calmette's
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D012882 Skin Tests Epicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity. Skin Test,Test, Skin,Tests, Skin
D037102 Lectins Proteins that share the common characteristic of binding to carbohydrates. Some ANTIBODIES and carbohydrate-metabolizing proteins (ENZYMES) also bind to carbohydrates, however they are not considered lectins. PLANT LECTINS are carbohydrate-binding proteins that have been primarily identified by their hemagglutinating activity (HEMAGGLUTININS). However, a variety of lectins occur in animal species where they serve diverse array of functions through specific carbohydrate recognition. Animal Lectin,Animal Lectins,Isolectins,Lectin,Isolectin,Lectin, Animal,Lectins, Animal

Related Publications

M J Gersten, and E M Hadden, and M H Kaplan, and C M Pinsky, and D Armstrong, and J W Hadden
March 1975, Cancer,
M J Gersten, and E M Hadden, and M H Kaplan, and C M Pinsky, and D Armstrong, and J W Hadden
May 1976, Cancer,
M J Gersten, and E M Hadden, and M H Kaplan, and C M Pinsky, and D Armstrong, and J W Hadden
February 1979, The American journal of nursing,
M J Gersten, and E M Hadden, and M H Kaplan, and C M Pinsky, and D Armstrong, and J W Hadden
August 1975, Deutsche medizinische Wochenschrift (1946),
M J Gersten, and E M Hadden, and M H Kaplan, and C M Pinsky, and D Armstrong, and J W Hadden
October 2019, Applied microbiology and biotechnology,
M J Gersten, and E M Hadden, and M H Kaplan, and C M Pinsky, and D Armstrong, and J W Hadden
February 1984, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
M J Gersten, and E M Hadden, and M H Kaplan, and C M Pinsky, and D Armstrong, and J W Hadden
March 1977, Archives of surgery (Chicago, Ill. : 1960),
M J Gersten, and E M Hadden, and M H Kaplan, and C M Pinsky, and D Armstrong, and J W Hadden
November 1978, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
M J Gersten, and E M Hadden, and M H Kaplan, and C M Pinsky, and D Armstrong, and J W Hadden
September 1981, Cancer,
M J Gersten, and E M Hadden, and M H Kaplan, and C M Pinsky, and D Armstrong, and J W Hadden
January 1981, Terapevticheskii arkhiv,
Copied contents to your clipboard!